Cardiac Failure Review

Scope & Guideline

Innovating the future of heart health.

Introduction

Immerse yourself in the scholarly insights of Cardiac Failure Review with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2057-7540
PublisherRADCLIFFE CARDIOLOGY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationCARD FAIL REV / Card. Fail. Rev.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIT F, BOURNE END BUSINESS PARK, BOURNE END, BUCKS SL8 5AS, ENGLAND

Aims and Scopes

The journal 'Cardiac Failure Review' is dedicated to advancing the understanding and management of heart failure through a comprehensive examination of its various aspects. The focus encompasses clinical, epidemiological, and therapeutic dimensions of heart failure, with an emphasis on innovative treatment strategies, diagnostic advancements, and patient-centered care.
  1. Heart Failure Management and Therapy:
    The journal emphasizes the latest developments in the management and therapeutic approaches to heart failure, including pharmacological treatments, device therapies, and patient education.
  2. Diagnostic Imaging and Biomarkers:
    A significant focus is placed on advancements in diagnostic imaging techniques and the identification of biomarkers that aid in the early detection, prognosis, and management of heart failure.
  3. Epidemiology and Public Health:
    Research published in the journal often addresses the epidemiological aspects of heart failure, including its global burden, demographic variations, and the impact of socioeconomic factors on patient outcomes.
  4. Multidisciplinary Approaches to Heart Failure Care:
    The journal highlights the importance of a multidisciplinary approach in heart failure management, integrating insights from cardiology, nursing, pharmacy, and public health.
  5. Emerging Therapies and Technologies:
    Innovations in treatment modalities, such as telemedicine and remote monitoring technologies, are explored to enhance patient management and outcomes.
The 'Cardiac Failure Review' has reflected emerging trends in heart failure research, highlighting new areas of focus that are gaining traction among researchers and clinicians. These trends indicate a shift towards more personalized, innovative, and comprehensive care models for heart failure patients.
  1. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF has surged, focusing on its unique challenges, treatment strategies, and the importance of this condition in the broader context of heart failure management.
  2. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote patient monitoring technologies has become increasingly prominent, particularly in light of the COVID-19 pandemic, emphasizing the need for innovative care solutions.
  3. Diversity and Health Disparities:
    There is a growing emphasis on understanding and addressing health disparities in heart failure care, particularly among minority populations, highlighting the importance of equitable healthcare access.
  4. Biomarkers and Personalized Medicine:
    The exploration of biomarkers for early detection and personalized treatment strategies is on the rise, reflecting a shift towards tailored therapy based on individual patient profiles.
  5. Multimodality Imaging:
    The use of multimodality imaging techniques to enhance diagnosis and treatment planning in heart failure is emerging as a critical theme, showcasing advancements in imaging technologies.

Declining or Waning

Over recent years, certain themes within the 'Cardiac Failure Review' have shown a decline in publication frequency, suggesting a shift in focus or a saturation of research in those areas. This decline may reflect evolving priorities in heart failure research or advancements that have rendered some topics less critical.
  1. Traditional Pharmacotherapy:
    While traditional pharmacotherapy for heart failure remains important, there has been a noticeable decline in articles focused on older classes of medications, as newer therapies and treatment strategies gain prominence.
  2. Basic Pathophysiological Studies:
    Research centered on basic pathophysiological mechanisms of heart failure has decreased, possibly due to a growing emphasis on clinical applications and translational research.
  3. Generalized Management Guidelines:
    Publications that reiterate general heart failure management guidelines without new insights or data have diminished, as the field moves towards more personalized and patient-specific treatment approaches.

Similar Journals

Frontiers in Cardiovascular Medicine

Pioneering Research in Cardiology and Beyond.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Journal of Cardiovascular Echography

Advancing the frontiers of cardiovascular imaging.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2211-4122Frequency: 4 issues/year

Journal of Cardiovascular Echography, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a premier platform for global researchers, medical professionals, and students dedicated to the ever-evolving fields of cardiology and cardiovascular imaging. With the ISSN 2211-4122 and E-ISSN 2347-193X, this journal provides access to cutting-edge research from 2011 to 2024, offering insights into the latest advancements in echocardiographic techniques and their clinical applications. Despite its current classification in the Q3 quartile within both Cardiology and Cardiovascular Medicine as well as Radiology, Nuclear Medicine, and Imaging, it continues to make meaningful contributions to the academic community, ranking 234th in the Scopus category for Radiology and 278th in Cardiology. The Journal of Cardiovascular Echography is committed to furthering knowledge and fostering collaboration among researchers by sharing critical developments in the field, making it an essential resource for anyone looking to stay abreast of transformational changes in cardiovascular diagnostics.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Driving evidence-based practices in cardiology.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

Revista Portuguesa de Cardiologia

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

CARDIOLOGY CLINICS

Innovating cardiology with comprehensive reviews and expert analysis.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

Journal of Cardiovascular Development and Disease

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

Journal of Cardiovascular Medicine

Connecting Research and Practice for Heart Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Exploring the Frontiers of Echocardiography
Publisher: WILEYISSN: 0742-2822Frequency: 12 issues/year

ECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.

TEXAS HEART INSTITUTE JOURNAL

Exploring Innovations in Heart Care and Research.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

CURRENT OPINION IN CARDIOLOGY

Navigating the latest trends in cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.